Predictors of Unfavorable Outcome in Intracranial Angioplasty and Stenting in a Single-Center Comparison: Results from the Borgess Medical Center-Intracranial Revascularization Registry

References

1. 1.↵
   1. Bonita R,
   2. Beaglehole R

   . Modification of Rankin Scale: recovery of motor function after stroke. Stroke 1988;19:1497–500

   Abstract/FREE Full Text
2. 2.↵
   1. Sundt TM,
   2. Smith HC,
   3. Campbell JK,
   4. et al

   . Transluminal angioplasty for basilar artery stenosis. Mayo Clin Proc 1980;55:673–80

   PubMedWeb of Science
3. 3.↵
   1. Derdeyn CP,
   2. Chimowitz MI

   . Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial. Neuroimaging Clin N Am 2007;17:355–63

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Connors JJ,
   2. Wojak JC

   . Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg 1999;91:415–23

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Marks MP,
   2. Wojak JC,
   3. Al-Ali F,
   4. et al

   . Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke 2006;37:1016–20

   Abstract/FREE Full Text
6. 6.↵
   1. du Mesnil de Rochemont R,
   2. Turowski B,
   3. Buchkremer M,
   4. et al

   . Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents—initial experience. Radiology 2004;231:45–49

   PubMedWeb of Science
7. 7.↵
   Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results. Stroke 2004;35:1388–92

   Abstract/FREE Full Text
8. 8.↵
   1. Kurre W,
   2. Berkefeld J,
   3. Sitzer M,
   4. et al

   . Treatment of symptomatic high-grade intracranial stenoses with the balloon-expandable Pharos stent: initial experience. Neuroradiology 2008;50:701–08

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Mazighi M,
   2. Yadav JS,
   3. Abou-Chebl A

   . Durability of endovascular therapy for symptomatic intracranial atherosclerosis. Stroke 2008;39:1766–69

   Abstract/FREE Full Text
10. 10.↵
    1. Bose A,
    2. Hartmann M,
    3. Henkes H,
    4. et al

    . A novel, self expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses. The Wingspan study. Stroke 2007;38:1531–37

    Abstract/FREE Full Text
11. 11.↵
    1. Chimowitz MI,
    2. Lynn MJ,
    3. Howlett-Smith H,
    4. et al

    . for the Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305–16

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Fiorella D,
    2. Levy EI,
    3. Turk AS,
    4. et al

    . US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007;38:881–87

    Abstract/FREE Full Text
13. 13.↵
    1. Zaidat OO,
    2. Klucznik R,
    3. Alexander MJ,
    4. et al

    . for the NIH Multi-center Wingspan Intracranial Stent Registry Study Group. The NIH registry on use of the Wingspan stent for symptomatic 70–99% intracranial arterial stenosis. Neurology 2008;70:1518–24

    Abstract/FREE Full Text
14. 14.↵
    1. Gröschel K,
    2. Schnaudigel S,
    3. Pilgram SM,
    4. et al

    . A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke 2009;40:e340–47

    Abstract/FREE Full Text
15. 15.↵
    1. Jiang WJ,
    2. Xu XT,
    3. Du B,
    4. et al

    . Long-term outcome of elective stenting for symptomatic intracranial vertebrobasilar stenosis. Neurology 2007;68:856–58

    Abstract/FREE Full Text
16. 16.↵
    1. Mori T,
    2. Fukuoka M,
    3. Kazita K,
    4. et al

    . Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol 1998;19:1525–33

    Abstract